TCM
TMO icon

Traynor Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Traynor Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-406
Closed -$211K – 320
2024
Q4 		$211K Buy
+406
New +$223K 0.01% 237
2016
Q3 		– Sell
-21,043
Closed -$1.28M – 135
2016
Q2 		$1.28M Buy
+21,043
New +$3.11M 1% 23

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Traynor Capital Management's TMO Position: Q1 2025 in Review

Traynor Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 406 shares — an estimated $211K sold.

Traynor Capital Management first reported a position in TMO in Q2 2016 and held it in 2 quarters. The position peaked at $1.28M in Q2 2016. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Traynor Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
  • Traynor Capital Management sold 406 Thermo Fisher Scientific shares in Q1 2025, an estimated $211K.
  • Traynor Capital Management first reported a position in Thermo Fisher Scientific in Q2 2016 and held it in 2 quarters.
  • Traynor Capital Management's Thermo Fisher Scientific position peaked at $1.28M in Q2 2016.
  • 2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Traynor Capital Management's 13F filing for Q1 2025, filed 12 May 2025.